{"id":528499,"date":"2010-04-15T10:22:09","date_gmt":"2010-04-15T14:22:09","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=73722"},"modified":"2010-04-15T10:22:09","modified_gmt":"2010-04-15T14:22:09","slug":"cell-therapeutics-cuts-36-employees","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/528499","title":{"rendered":"Cell Therapeutics Cuts 36 Employees"},"content":{"rendered":"\n
Biotech<\/a>, people<\/a>, Layoffs<\/a><\/div>\n

\t\tLuke Timmerman wrote:<\/strong><\/p>\n

Cell Therapeutics (NASDAQ: CTIC<\/a>), the Seattle-based biotech company, said<\/a> it has cut 36 jobs to conserve cash. The move comes less than a week after the company’s application to sell a new drug for non-Hodgkin’s lymphoma was rejected by the FDA. The company says it now expects to spend about $60 million on operations this year, down 21 percent from its previous forecast.<\/p>\n

Comments<\/a> | Reprints<\/a> | Share:  
\n\"Retweet\"\/<\/a>
\n \"Facebook\"\/<\/a>
\n \"Email\"\/<\/a>
\n \"Share\"\/<\/a>\n<\/div>\n

\t \t\t

\n

\n\"\"<\/a>
\n\"\"<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Biotech, people, Layoffs Luke Timmerman wrote: Cell Therapeutics (NASDAQ: CTIC), the Seattle-based biotech company, said it has cut 36 jobs to conserve cash. The move comes less than a week after the company’s application to sell a new drug for non-Hodgkin’s lymphoma was rejected by the FDA. The company says it now expects to spend […]<\/p>\n","protected":false},"author":1192,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-528499","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/528499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1192"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=528499"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/528499\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=528499"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=528499"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=528499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}